Saturday, January 28, 2012

What are hormones?

In a general sense hormones are the body’s messenger service. There are over 40 known hormones that act within the body. They are each released by a specific endocrine gland (such as the pituitary gland, adrenal glands, pancreas or testes / ovaries) in response to a specific stimulus, possibly another hormone. A hormone is released to generate a specific result. In normal circumstances the hormonal system works on a negative feedback mechanism.

A stimulus causes the endocrine gland to release a hormone -> The hormone causes the stimulus to be stopped or reduced -> The endocrine gland stops producing the hormone

The classic example is the role of insulin in the role of maintaining the blood sugar levels. Insulin is only released in response to an increase in sugar levels, as soon as blood sugar levels falls; the production of insulin is stopped. The breakdown in this regulation causes the most common hormonal diseases – diabetes mellitus.

In normal puberty the pathway is:

Hypothalamus gland produces GnRH (gonadotrophin releasing hormone)

Which causes the

Pituitary gland to produce LH & FSH (luteinsing hormone / follicle stimulating hormone)

Which cause the

Testes to produce testosterone & sperm

Or

Ovaries to produce progesterone and oestrogen & allow ovulation to occur

The sex hormones also have other effects around the body, not just linked to puberty and fertility.

In KS or HH either the pituitary gland does not receive the GnRH, or it is unable to respond to the GnRH. Without the first signal the pituitary will not produce its hormones (LH and FSH) that in turn will prevent the testes or ovaries producing their own hormones at the required time to cause puberty. For some people with KS / HH there is no physical problem with the testes or ovaries, they just have not had correct signal from the pituitary gland in order to function correctly.

The treatments people get with KS / HH will be replacing one of the hormones missing in the chain. Normally this is either testosterone or oestrogen / progesterone. However it is also possible to be given FSH / LH or GnRH in certain circumstances, especially if fertility is desired.

Can a person with KS or HH become fertile?

Yes, possibly, but only with specialist treatment and if other circumstances are favourable. There have been many cases of people with KS / HH having children, sometimes through a form of IVF or other assisted fertilisation programmes. As with any type of fertility treatment there are many other factors to consider and it can take many months of treatment and there is no guarantee as with any form of fertility treatment. It has been noted that fertility can be achieved with Kallmann’s women more quickly than with other patients.

Is there any effect on expected lifespan?

There is no reliable evidence that KS or HH has any effect on the life span on an individual. It is worth point bearing in mind though that there are some rare symptoms that can occur with KS and HH that may have an effect on life span. These other symptoms may be connected to KS or HH or may have arisen regardless.

Are there any risks if KS or HH is left untreated?

Yes there can be. The major problem with a person with untreated KS or HH is the increased risk of osteoporosis or ‘brittle bone disease’. The greatly reduced levels of sex hormones seen with KS and HH have a detrimental effect on the strength of the bones. This can be easily treated with the appropriate drugs that will reduce the risk of osteoporosis to that seen in the rest of the population. It is advised that a person with KS or HH should have a bone scan (DEXA) at least every 5 years to assess their bone age and to assess the risk of osteoporosis. There is increasing evidence that Vitamin D levels play a vital role general health, not just bone strength. It is not unknown for people with KS / HH to have their Vitamin D levels monitored and prescribed tablets if the level is too low.

Sunday, January 15, 2012

A patient’s perspective:

 “Long term psychological effects of delayed diagnosis of Hypogonadotrophic Hypogonadism in patients with delayed puberty”.


"Puberty is considered to be clinically delayed if sexual maturation has not become apparent by the age of 14 years in boys or age 13 years in girls."
"Using these criteria, approximately 2.5% of healthy adolescents will be identified as having pubertal delay"

Delayed Puberty. Rosen, DS, Foster C. Pediatrics in Review 2001;22;309


While the majority of these individuals will go on to experience normal puberty, albeit a couple of years later than their peer group; there is a perhaps a need to evaluate all patients who appear to be delayed to eliminate other causes for their pubertal failure.

One possible cause of a delay or absence of puberty is Kallmann syndrome (KS) and other forms of hypogonadotrophic hypogonadism (HH). Most cases are not detected as adolescents, even if they display the anosmia seen in KS. Both KS and HH show variable physical symptoms even within family members, which in addition to the absence of a clear cut genetic test make diagnosis of KS and HH problematic at times.

Combined KS and HH have a probable incidence of approximately 1 in 4,000 males and 1 in 25,000 females. Without treatment patients will remain infertile with no or poorly defined secondary sexual characteristics and be at increased risk of developing osteoporosis.

From a patient’s point of view I feel there is a need to ensure that any adolescent with pubertal delay should be referred on for an endocrinology review. The benefits of early diagnosis and treatment of KS / HH both on a physical level and on a psychological level cannot be overestimated. An early endocrine review will be able separate a case of normal constitutional delay of puberty from a case which will require extra investigation.

From my own personal experience and from conversations with others in patient support groups the label of “late bloomer” or “late developer” can lead onto deeper psychological issues later in life as patients get left behind both physically and emotionally from their own peer group.

The social isolation some patients feel can be avoided by early diagnosis and treatment. It is clear from conversations within our support groups the earlier a diagnosis is made and the correct treatment started the more beneficial it is to the patient in later life. The ability to put a name to the condition would at least allow the patient to know there is a reason for the absence of puberty and they are not alone with the condition.

Neil Smith.

neilsmith38@hotmail.com
www.kallmanns.org